packageEtirinotecanPegol

etirinotecan pegol

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Etirinotecan pegol is an investigational topoisomerase inhibitor studied as a cancer treatment, mainly for breast cancer. It has not been approved; a marketing application in the European Union was refused.

Unverified — written by glm-5.3-flash from general knowledge (no Wikidata entry found) and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:etirinotecan pegol
ATC codes:L01CE03
DrugBank:DB14951

Metabolites

APCAPC618.687 g/mol (paper)
Irinotecanirinotecan586.678 g/mol (paper)
SN38SN38382.404 g/mol (paper)
SN38GlucuronideSN38-glucuronide568.53 g/mol (paper)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
APCmetabolite: APC
Irinotecanmetabolite: irinotecan
SN38metabolite: SN38
SN38Glucuronidemetabolite: SN38-glucuronide